COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,668 Articles (22,913 medRxiv, 8,755 bioRxiv)

Most recent first Previous |  Page 2790: Articles 27891-27900  | Next

Super spreader cohorts and covid-19
Van Esch, P.
10.1101/2020.05.15.20103184 — Posted: 2020-05-20
An Age and Space Structured SIR Model Describing the Covid-19 Pandemic
Colombo, R. M., Garavello, M., Marcellini, F., Rossi, E.
10.1101/2020.05.15.20103317 — Posted: 2020-05-20
The Seasonal End of Human Coronavirus Hospital Admissions with Implications for SARS-CoV-2
Evangelista, A. T.
10.1101/2020.05.15.20103416 — Posted: 2020-05-20
Feasibility of non-invasive nitric oxide inhalation in acute hypoxic respiratory failure: potential role during the COVID-19 pandemic
Shekar, K., Varkey, S., Cornmell, G., Parsons, L., Tol, M., Siuba, M., Ramanan, M.
10.1101/2020.05.17.20082123 — Posted: 2020-05-20
Early assessment of knowledge, attitudes, anxiety and behavioral adaptations of Connecticut residents to COVID-19
Ha, T., Schensul, S., Lewis, J., Brown, S.
10.1101/2020.05.18.20082073 — Posted: 2020-05-20
Serological prevalence of antibodies to SARS CoV-2 amongst cancer centre staff
Sikora, K., Barwick, I., Hamilton, C.
10.1101/2020.05.16.20099408 — Posted: 2020-05-20
Hyperpyrexia leading to death in a patient with severe COVID-19 disease
Singhal, T., Phadtare, S., Pai, S., Raodeo, A.
10.1101/2020.05.18.20097220 — Posted: 2020-05-20
Changing trends of excess self-protective behavior, and association with belief in prevention myths during the COVID-19 epidemic in China: A panel study
Yousef Yang, X., peng, S., Yang, T., Rockett, I. R. H.
10.1101/2020.05.18.20102434 — Posted: 2020-05-20
Performance of progressive and adaptive COVID-19 exit strategies: a stress test analysis for managing intensive care unit rates
van Wees, J.-D., van der Kuip, M., Osinga, S., van Westerloo, D., Tanck, M., Hanegraaf, M., Pluymaekers, M., Leeuwenburgh, O., van Bijsterveldt, L., Verreijdt, P., Brunner, L., Tutu van Furth, M.
10.1101/2020.05.16.20102947 — Posted: 2020-05-20
Estimating the cost-of-illness associated with the COVID-19 outbreak in China from January to March 2020
Jin, H., Wang, H., Li, X., Zheng, W., Ye, S., Zhang, S., Zhou, J., Pennington, M.
10.1101/2020.05.15.20102863 — Posted: 2020-05-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).